| Cash and cash equivalents |
138.87M |
| Accounts receivable, less allowance of $1,741 at July 2, 2011 and $1,799 at April 2, 2011 |
151.6M |
| Inventories, net |
194.51M |
| Deferred tax asset, net |
| Prepaid expenses and other current assets |
27.41M |
| Total current assets |
512.39M |
| Land, building and building improvements |
| Plant equipment and machinery |
| Office equipment and information technology |
| Haemonetics equipment |
| Total property, plant and equipment |
| Less: accumulated depreciation |
| Net property, plant and equipment |
339.84M |
| Intangible assets, less amortization of $46,707 at July 2, 2011 and $43,827 at April 2, 2011 |
192.45M |
| Goodwill |
268.55M |
| Deferred tax asset, long term |
7.94M |
| Other long-term assets |
13.66M |
| Total other assets |
| Total assets |
1.33B |
| Notes payable and current maturities of long-term debt |
51.55M |
| Accounts payable |
42.01M |
| Accrued payroll and related costs |
40.81M |
| Accrued income taxes |
| Deferred tax liability |
| Other liabilities |
64.29M |
| Total current liabilities |
198.66M |
| Long-term debt, net of current maturities |
336.51M |
| Long-term deferred tax liability |
22.19M |
| Other long-term liabilities |
28.36M |
| Commitments and contingencies (Note 12) |
| Common stock, $0.01 par value; Authorized - 150,000,000 shares; Issued and outstanding- 25,770,869 at July 2, 2011 and 25,660,393 shares at April 2, 2011 |
515K |
| Additional paid-in capital |
459.65M |
| Retained earnings |
325.66M |
| Accumulated other comprehensive income |
-36.72M |
| Total stockholders' equity |
749.11M |
| Total liabilities and stockholders' equity |
1.33B |
